HUTCHMED’s Fanregratinib gains priority review in China for aggressive liver cancer
Co-Diagnostics scores major IP win in Australia with first patent for PCR platform
Johnson & Johnson completes $3.05 billion acquisition of Halda Therapeutics
Wockhardt’s WCK 5222 earns accelerated review from European Medicines Agency
StimLabs secures FDA nod for groundbreaking human umbilical cord-derived device
SOFIE Biosciences doses first patient in Phase 3 trial of novel cancer imaging agent
WORK Medical scores regulatory approval for AI-powered blood analyzer
Establishment Labs seeks FDA nod for Motiva breast reconstruction implants
Enveric Biosciences bags key US patent for next-gen neuropsychiatric drugs
Ultragenyx’s Setrusumab falls short in Phase 3 osteogenesis imperfecta trials
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes